AstraZeneca Aktie
127,80
EUR
+3,55
EUR
+2,86
%
1.375,50
SEK
+19,00
SEK
+1,40
%
Werbung
AstraZeneca Aktie Analyse
| 26.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 13.07.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 09.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 15.06.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.06.18 | AstraZeneca buy | Deutsche Bank AG | |
| 29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 22.05.18 | AstraZeneca overweight | Barclays Capital | |
| 22.05.18 | AstraZeneca buy | Deutsche Bank AG | |
| 18.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 15.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 11.05.18 | AstraZeneca overweight | Barclays Capital | |
| 24.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.04.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 13.04.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.03.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 14.03.18 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 27.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.02.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.02.18 | AstraZeneca buy | Deutsche Bank AG | |
| 06.02.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 05.02.18 | AstraZeneca buy | Deutsche Bank AG | |
| 02.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.01.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.01.18 | AstraZeneca buy | Deutsche Bank AG | |
| 29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.12.17 | AstraZeneca buy | Deutsche Bank AG | |
| 08.11.17 | AstraZeneca buy | Citigroup Corp. | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | AstraZeneca buy | Deutsche Bank AG | |
| 16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
| 22.09.17 | AstraZeneca Outperform | Bernstein Research | |
| 19.09.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 11.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 11.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 07.09.17 | AstraZeneca buy | Citigroup Corp. | |
Werbung
Werbung